Overview

Oral Flurbiprofen Spray for Mucosal Graft Harvesting at the Palatal Area

Status:
Completed

Trial end date:
2017-03-01

Target enrollment:
0

Participant gender:
All

Summary

Connective tissue graft (CTG) and free gingival graft (FGG) harvesting from the palatal area has been used frequently in the periodontal mucogingival surgery and reported to provide higher predictability and success regarding esthetic outcomes. The aim of the study was to evaluate the effects of oral flurbiprofen spray on wound healing, postoperative patient morbidity and discomfort after palatal graft harvesting. Forty eight patients scheduled for CTG and FGG requiring periodontal plastic surgeries were selected. The patients were randomly assigned to each group, and used oral spray of flurbiprofen or placebo 3 times a day for a week. The palatal donor area was evaluated at 1 and 3 days and 1, 2, 3, 4, 6 and 8 weeks postsurgery for postoperative pain, complete epithelization, feeding habits, color match, and total number of analgesic pills taken. The Wound-Healing Index (WHI) was recorded at 2-week follow up.

Phase:

Early Phase 1

Accepts Healthy Volunteers?

Accepts Healthy Volunteers

Details

Lead Sponsor:

Gazi University

Treatments:

Flurbiprofen

Criteria

Inclusion Criteria:

1. age > 18 years,

2. not having any systemic disease that could compromise wound healing,

3. no periodontal surgery on the experimental sites before,

4. no smoking,

5. no pregnancy or lactation.

Exclusion Criteria:

1. hypersensitivity to flurbiprofen,

2. history of allergy to NSAIDs,

3. having coagulation disorders,

4. presence of gagging reflex.